-
H-
13-30MeV
-
D-
7-15MeV
-
He++
20-30MeV
Expanding the Boundaries of Precision Diagnosis and TherapyIntegrated Multi-Scenario Application
- As the source equipment for the aforementioned clinical applications, the LB-30 series can cover multiple application scenarios in a one-stop manner, laying a solid equipment foundation for the clinical popularization, application deepening, and frontier exploration of precision nuclear medicine diagnosis and therapy technologies.
- In diagnosis, nuclear medicine imaging combined with molecular information enables early detection and precise typing; in therapy, radionuclide-targeted drugs physically overcome tumor resistance and heterogeneity, while precise radiotherapy utilizes various mechanisms to target and kill cancer cells, reducing damage to normal tissues.
Production of Novel Diagnostic Radionuclides
- 203Pb
- 99mTc
- 111In
- 123I
- 168Ge
- 61Cu
- 89Zr
- 68Ga
- 64Cu
- 18F
Novel Therapeutic Radionuclides
- 211At
- 225Ac
- 67Cu
- 177Lu
BNCT Neutron Source
- n+10B→7Li+α
Customized to Meet Diverse Customer NeedsModular Product Portfolio
We consistently focus on the diverse needs of customers, exclusively developing modular product combinations tailored to different customer groups, including:
• Multi-Particle Type: Suitable for customers with diverse research directions and certain scientific research attributes.
• Single-Ion High-Current Type: Suitable for customers with specific usage directions, pursuing performance for industrial production.
Integrated Isotope Production Solution
We deeply understand the importance of providing an overall isotope production solution. For different nuclides, we provide a complete set of nuclide production equipment and processes with fully independent intellectual property rights, helping customers achieve:
• Automated and intelligent operation compliant with GMP regulations
• Comprehensive nuclide coverage
• High-standard production capacity guarantee
Automated Process
- Target Dissolution/Evaporation
- Radionuclide Separation/Purification
- Dispensing and Delivery
- Target Preparation
- Cyclotron Irradiation
Partial Nuclide Yields
Diagnostic Nuclides (PET/SPECT)
-
15Ci/2h
18O (p,n) 18F
-
400mCi/20min
16O(p,α)13N
-
3Ci/30min
14N (p, α) 11C
-
7.0mCi/μAh
64Ni (p,n) 64Cu
-
600mCi/3h
natZn(p,x)61Cu
-
10000mCi/1h
68Zn(p,n)68Ga
-
0.6mCi/μAh
89Y(p,n) 89Zr
-
0.5mCi/μAh
124Te(p,n)124I
-
8.5mCi/μAh
100Mo(p,2n)99mTc
-
9.0mCi/μAh
111Cd(p,n)111In
-
65.0mCi/μAh
124Xe(p,n)123Cs123Xe->123I
Ge/Ga Generator Source Material
-
0.05mCi/μAh
natGa(p,x)68Ge
Therapeutic Nuclides
-
100mCi/5d
226Ra(p,2n)225Ac
-
300mCi/8h
natBi(α,2n)2111At
Comprehensive Project Solution
Purchasing a cyclotron is only the first step in project construction. We not only provide advanced accelerator equipment but are also committed to becoming a comprehensive partner for our customers by offering a full suite of isotope production processes, equipment, and operational solutions.
We have a professional and experienced project construction and technical support team, providing a full lifecycle solution covering project planning, compliance, construction, operation, and decommissioning.
-
Definition
Equipment configuration advisory and nuclide production capacity/variety planning
-
Planning
On-site Planning and Verification
-
Compliance
Environmental impact assessment and GMP review support
-
Construction
Equipment installation and commissioning
-
Operation
Operational support, after-sales service, and scientific research collaboration




